Bausch + Lomb, Inc.

Bausch + Lomb, Inc.

Bausch + Lomb, Inc.

Overview
Date Founded

1989

Headquarters

1400 North Goodman Street,Rochester, NY 14609

Type of Company

Private

Employees (Worldwide)

11K

Industries

Medical Products & Equipment
Hospitals & Patient Services
Wholesale: Medical Supplies & Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Biotechnology

Company Description

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Website
Contact Data
Trying to get in touch with decision makers at Bausch + Lomb, Inc.? Subscribe today to access their professional contact information.
Executives & Employees

AR Process Owner

Executive Vice President & Chief Operating Officer

Senior Vice President & General Manager, US Vision Care

General Manager

Partner

Board of Directors

Special Limited Partner, Healthcare & Consumer at Warburg Pincus LLC

Executive Officer at Vnomics Corp.

Paths to Bausch + Lomb, Inc.
Potential Connections via
Relationship Science
You
Bausch + Lomb, Inc.
Recent Transactions
Details Hidden

Valeant Pharmaceuticals International, Inc., Bausch + Lomb, Inc. purchase Doctor's Allergy Formula LLC

Details Hidden

Valeant Pharmaceuticals International, Inc. purchases Bausch + Lomb, Inc. from Warburg Pincus & Company US LLC

Details Hidden

Bausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase Technolas Perfect Vision GmbH from 20/10 Perfect Vision Operations GmbH

Transaction Advisors
Accountant

Advised onBausch + Lomb, Inc. purchases Storz Instrument Co. from Wyeth Corp.

Accountant

Advised onBausch + Lomb, Inc. purchases Sino Concept Technology Ltd. from Sino Biopharmaceutical Ltd.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner at Connell Foley LLP

Legal Advisor

Senior Counsel at Cahill Gordon & Reindel LLP

Legal Advisor

Partner at Friedman Kaplan Seiler & Adelman LLP

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$2.46B
Non-Profit Donations & Grants
$1,000 - $4,999
2012
$1,000 - $2,500
2011
$1,000 - $2,499
2010
Non-Profit Donations & Grants Received
$64.5K
12/31/2011
Investments
Details Hidden

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

Details Hidden

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client’s use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Investors
Details Hidden

Partners Group-PE is an active, long-term manager which follows an integrated approach to make direct, secondary and primary investments in private equity, leveraging their global network to source, analyze and execute a range of investments across asset classes globally.The firm makes direct private equity investments into the equity of selected operating companies, typically together with investee management and taking a board seat. They make primary investments in newly established private equity partnerships where underlying portfolio companies are not known at the time of investment.They utilize relative value assessment for different regions and financing stages to select the best private equity segments, seeking to identify and invest with high-quality partners from among their relationships with global private markets managers, advisory board committees and general and limited partners.Partners Group-PE makes secondary investments by acquiring single or portfolios of assets on the secondary market across all asset classes and offering investors liquidity or an exit possibility in a market which is highly liquidity-constrained. They are a value-based secondary investor which understands individual portfolio assets and business models at the fundamental level. They aim to create value by acquiring high quality assets with significant value potential and/or undervalued assets at their point of inflection and searching for non-competitive acquisitions.

Details Hidden

Thomas, McNerney & Partners (TMP) invests in life science and medical technology companies at all stages of development. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. They are particularly interested in companies that are developing therapeutic products for life threatening or costly, chronic health conditions.TMP may invest in start-up companies, provide growth capital to emerging companies and participate in restructuring transactions including spin-outs, roll-ups and recapitalizations.TMP typically invests $5 million to $40 million in one or more rounds of financing, with an average investment of more than $15 million over the life of an investment. Initial investments may be as small as $100,000. The firm prefers to lead the financing round in which they first participate.TMP looks for companies with a focus on large, rapidly growing and underserved market segments that are ready to undergo change. Companies should be able to achieve a leadership position or have already established one in targeted market segments. They should have a convincing business model with the potential to achieve significant, sustainable value with reasonable risk. TMP also seeks companies with strong leadership, reasonable regulatory timelines with well-defined endpoints, technology development that integrates existing technologies in new ways, a case for acceptable product reimbursement and a solid intellectual property position.

Details Hidden

Founded 1979, Welsh, Carson, Anderson & Stowe is a private equity firm located in New York City.